Search - tctmd.com

Displaying 21 - 40 of 44

Sort: Relevancy | Date

Presentation TCT 2024

TCT 449: Long Term Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease

Presenter: Hesham Refaat

October 28, 2024

Presentation TCT 2024

TCT 445: Three-Year Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents for Small Coronary Arteries: A Systematic Review and Meta-Analysis

Presenter: Jeremy Levett

October 28, 2024

Presentation TCT 2024

TCT 405: Drug Coated Balloons in EuroCTO Registry

Presenter: Niccolò Ciardetti

October 27, 2024

Presentation TCT 2024

TCT 406: Outcomes in Patients With Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention With Drug-Coated Balloons

Presenter: HUAN YEAN KANG

October 27, 2024

Presentation TCT 2024

TCT 853: Drug-Coated Balloons in Calcified Lesions: Managing the Rock Without Metal

Presenter: Gianluca Mincione

October 27, 2024

Presentation TCT 2024

TCT 1536: Drug-Coated Balloons: A Novel Option for Cardiac Allograft Vasculopathy

Presenter: Clara Fernandez Cordon

October 27, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News ESC 2024

REC-CAGEFREE I: DCB Fails to Match Up to DES for De Novo CAD

Todd Neale

September 09, 2024

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

Michael O'Riordan

August 13, 2024

News Industry News

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

June 18, 2024

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

News Daily News

As US Rollout Begins for Coronary DCBs, Interventionalists Mull Practice Changes

Todd Neale

May 03, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Daily News

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

L.A. McKeown

April 24, 2024

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Caitlin E. Cox

April 10, 2024

News Daily News

DCB in STEMI Match DES Through 5 Years: REVELATION

Caitlin E. Cox

March 27, 2024

News Daily News

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

L.A. McKeown

March 25, 2024

News Conference News CRT 2024

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

L.A. McKeown

March 14, 2024

Presentation CTO 2024

The Dawn of Drug Coated Balloons, In-stent Restenosis, and Beyond

Presenter: Ajay J. Kirtane

February 03, 2024

News Conference News ISET 2024

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Caitlin E. Cox

January 31, 2024

Advertisement

TCT 449: Long Term Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease

TCT 445: Three-Year Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents for Small Coronary Arteries: A Systematic Review and Meta-Analysis

TCT 405: Drug Coated Balloons in EuroCTO Registry

TCT 406: Outcomes in Patients With Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention With Drug-Coated Balloons

TCT 853: Drug-Coated Balloons in Calcified Lesions: Managing the Rock Without Metal

TCT 1536: Drug-Coated Balloons: A Novel Option for Cardiac Allograft Vasculopathy

What’s Going to Be Big at TCT 2024?

REC-CAGEFREE I: DCB Fails to Match Up to DES for De Novo CAD

DES Best for In-Stent Restenosis, but DCBs Also Viable

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

As US Rollout Begins for Coronary DCBs, Interventionalists Mull Practice Changes

FDA Approves Bioresorbable Scaffold for BTK Lesions

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

DCB in STEMI Match DES Through 5 Years: REVELATION

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

The Dawn of Drug Coated Balloons, In-stent Restenosis, and Beyond

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content